4 Midcap Profit Growth Above Long-Term Average Stocks to Watch for Future Multibagger Potential: Coforge, MCX, SRF and Fortis Healthcare

Profit growth above long-term average stocks to watch for multibagger potential start with a simple filter: size, a clean financial record and earnings that keep growing. Coforge, MCX, SRF and Fortis Healthcare meet that test, with market caps from Rs 57,814 crore to Rs 88,796 crore and Coforge offering the largest market cap at Rs 88,796 crore. Each of these companies has a market capitalisation between Rs 30,000 crore and Rs 1,00,000 crore and FY26 net profit growth at least 5 percentage points above its FY22 to FY26 compound annual growth rate, a return on equity of at least 10 per cent and profit growth in FY26 and in the latest quarter, and net profit rose in FY26 and in the latest quarter.

This list covers companies with a market capitalisation between Rs 30,000 crore and Rs 1,00,000 crore and FY26 net profit growth at least 5 percentage points above its FY22 to FY26 compound annual growth rate, a return on equity of at least 10 per cent and profit growth in FY26 and in the latest quarter, rising profit in FY26 and the latest quarter, and complete, verifiable financials, ranked by market capitalisation. Each company has a market cap between Rs 30,000 crore and Rs 1 lakh crore. Investors screening profit growth above long-term average stocks usually begin with size and balance sheet strength, and this list follows the same logic. All figures are as of 28 October 2026 and are drawn from NSE and BSE data and company filings.

Click Here – Get Free Investment Predictions

What Are Profit Growth Above Long-Term Average Stocks and Why Do They Attract Multibagger Interest?

Profit growth above long-term average stocks are shares of mid sized companies whose profit grew faster in FY26 than the average pace of the last four years, a sign that growth is speeding up and not slowing down. The four here cover IT services, specialty chemicals, commodity exchange services and hospitals.

Profit that grows faster than its own long term average shows that the business is gathering pace, which is the kind of momentum that long term investors look for. For profit growth above long-term average stocks, both FY26 and the latest quarter showed growth. A sensible way to study profit growth above long-term average stocks is to look at profit growth, returns and valuation side by side. Below, each of profit growth above long-term average stocks gets its own breakdown of growth, returns and valuation. Treat profit growth above long-term average stocks as a research list, since share prices and rankings change with every earnings season.

Profit Growth Above Long-Term Average Stocks at a Glance: Price, Market Cap, PE and ROE

Prices are closing prices as of 28 October 2026. SRF has the lowest PE of the group at 34.48, while MCX posts the highest return on equity at 46.75%.

Stock	CMP (Rs)	Market Cap (Rs Cr)	PE	Industry PE	ROE	Debt to Equity	52-Week Range (Rs)
Coforge	1,961.90	88,796	46.24	17.66	16.31%	0.08	1,008.10 to 2,021.20
Multi Commodity Exchange of India	3,180.60	82,353	53.41	42.17	46.75%	0.00	1,762.10 to 3,481.40
SRF	2,350	74,551	34.48	36.15	13.07%	0.36	2,310.00 to 3,210.00
Fortis Healthcare	759.50	57,814	54.01	60.75	10.53%	0.35	565.00 to 759.50

Coforge: 23.72% Profit CAGR Since FY22

Coforge is an IT services company serving clients in travel, banking, insurance and other industries. It reported FY26 revenue of Rs 16,475.90 crore, up 34.63% year on year, and net profit of Rs 1,674.50 crore, up 73.79%. Net profit has compounded at 23.72% a year since FY22, while revenue has grown 26.26% a year. Operating margin was 17.40% in FY26. The debt-to-equity ratio is 0.08, which keeps interest costs low.

In the June 2026 quarter, revenue rose 49.19% to Rs 5,554.50 crore and net profit grew 49.19% to Rs 531.70 crore. The share price has gained 73.24% over five years and 10.25% over the past year. The stock trades at a PE of 46.24 against an industry PE of 17.66, with a return on equity of 16.31%.

MCX: 74.55% Profit CAGR Since FY22

MCX is India’s leading commodity derivatives exchange, where gold, silver, crude oil, natural gas and base metals contracts are traded. It reported FY26 revenue of Rs 2,429.05 crore, up 100.94% year on year, and net profit of Rs 1,331.55 crore, up 137.76%. Net profit has compounded at 74.55% a year since FY22, while revenue has grown 53.87% a year. Operating margin was 76.83% in FY26. The debt-to-equity ratio is 0.00, which keeps interest costs low.

The stock trades at a PE of 53.41 against an industry PE of 42.17, with a return on equity of 46.75%. In the June 2026 quarter, revenue rose 85.25% to Rs 751.79 crore and net profit grew 103.47% to Rs 413.44 crore. The share price has gained 720.06% over five years and 69.44% over the past year. Foreign investors raised their holding from 21.69% in June 2025 to 29.84% in June 2026.

SRF: Quarterly Profit Up 75.53%

SRF operates in specialty chemicals, packaging films and technical textiles, and its chemicals business is a key earnings driver. It reported FY26 revenue of Rs 15,893.57 crore, up 7.20% year on year, and net profit of Rs 1,835.18 crore, up 46.72%. Revenue has compounded at 6.08% a year since FY22. Operating margin was 21.74% in FY26. The debt-to-equity ratio is 0.36.

In the June 2026 quarter, revenue rose 31.69% to Rs 5,067.17 crore and net profit grew 75.53% to Rs 758.87 crore. Domestic institutions raised their holding from 18.85% in June 2025 to 22.44% in June 2026. The stock trades at a PE of 34.48 against an industry PE of 36.15, below the sector average, with a return on equity of 13.07%.

Fortis Healthcare: Five-Year Gain of 241.47%

Fortis Healthcare operates a chain of hospitals and diagnostic centres across India. It reported FY26 revenue of Rs 9,178.50 crore, up 16.93% year on year, and net profit of Rs 1,064.19 crore, up 31.48%. Net profit has compounded at 7.73% a year since FY22, while revenue has grown 12.43% a year. Operating margin was 22.41% in FY26. The debt-to-equity ratio is 0.35.

The stock trades at a PE of 54.01 against an industry PE of 60.75, below the sector average. In the June 2026 quarter, revenue rose 17.29% to Rs 2,559.50 crore and net profit grew 2.26% to Rs 272.80 crore. The share price has gained 241.47% over five years. Domestic institutions raised their holding from 29.79% in June 2025 to 32.23% in June 2026.

Profit Growth Above Long-Term Average Stocks: Financial Comparison on Growth and Margins

The table compares scale and growth across these profit growth above long-term average stocks. Latest quarter means the most recent reported quarter for each company, and only metrics that are positive for every company are shown.

Stock	Revenue (Rs Cr)	Net Profit (Rs Cr)	Revenue Growth (YoY)	4-Year Revenue CAGR	Latest Quarter Revenue Growth	Operating Margin (Latest Quarter)
Coforge	16,475.90	1,674.50	34.63%	26.26%	49.19%	18.63%
MCX	2,429.05	1,331.55	100.94%	53.87%	85.25%	77.49%
SRF	15,893.57	1,835.18	7.20%	6.08%	31.69%	25.73%
Fortis Healthcare	9,178.50	1,064.19	16.93%	12.43%	17.29%	22.22%

Check the Univest Screener for live data on these profit growth above long-term average stocks

Institutional Holding in Coforge, MCX, SRF and Fortis Healthcare

Institutional holding shows who is backing these profit growth above long-term average stocks alongside the promoter. The table uses the latest reported quarter for each. MCX has the deepest institutional backing, with FII and DII together holding 80.65% as of June 2026. Domestic institutions increased their holding over the past year in SRF (from 18.85% to 22.44%) and Fortis Healthcare (from 29.79% to 32.23%).

Stock	Promoter	FII	DII	Public	Quarter
Coforge	Nil	24.31%	42.62%	33.07%	June 2026
MCX	Nil	29.84%	50.81%	19.34%	June 2026
SRF	50.26%	15.45%	22.44%	11.85%	June 2026
Fortis Healthcare	31.17%	25.20%	32.23%	11.40%	June 2026

Risks to Weigh in Profit Growth Above Long-Term Average Stocks

Being careful with profit growth above long-term average stocks means looking at what can slow the story as well as what can speed it up. Four points matter most:

• Past growth may not repeat.
• Share prices can move sharply in either direction.
• Valuation: Coforge trades at a PE of 46.24 against an industry PE of 17.66, so earnings need to keep growing to support the price.
• Concentration: Holding all 4 names puts the allocation in one sector, so size each position to match your risk appetite.

How to Choose Between Profit Growth Above Long-Term Average Stocks

Picking from profit growth above long-term average stocks comes down to four checks, applied in order.

1. Check balance sheet strength first, and prefer a debt-to-equity ratio below 1 for non-financial companies.
2. Compare each PE with the industry PE (17.66 to 60.75) and ask whether the growth rate justifies any gap.
3. Track net profit growth, the operating margin and the return on equity in every quarterly result.
4. Stagger entries across quarters and review institutional holding every reporting season.

Download the Univest iOS App or Univest Android App to track Coforge, MCX, SRF and Fortis Healthcare live prices.

Conclusion

Among profit growth above long-term average stocks, Coforge stands out for the largest market cap at Rs 88,796 crore, MCX for the highest return on equity at 46.75%, SRF for the lowest PE of the group at 34.48 and Fortis Healthcare for 16.93% revenue growth in FY26. Which one suits a portfolio depends on how much valuation risk it can carry, so staggering entries and reviewing each quarterly result is a sound habit. Investors comparing profit growth above long-term average stocks should rank them on growth, financial strength and the price paid, and anyone who wants personalised guidance can consult a SEBI-registered advisor before acting.

Frequently Asked Questions on Profit Growth Above Long-Term Average Stocks to Watch

Which are the best profit growth above long-term average stocks to watch for multibagger potential?

Ans. Coforge, MCX, SRF and Fortis Healthcare are the 4 names this list highlights, with market caps of Rs 88,796 crore, Rs 82,353 crore, Rs 74,551 crore and Rs 57,814 crore respectively. Coforge is notable for the largest market cap at Rs 88,796 crore. MCX stands out for the highest return on equity at 46.75%. SRF offers the lowest PE of the group at 34.48. Fortis Healthcare brings 16.93% revenue growth in FY26. These are watchlist names for profit growth above long-term average stocks, not recommendations, so match each one to your own risk profile and time horizon.

Is MCX a good stock for long-term investors?

Ans. MCX has a return on equity of 46.75%, a PE of 53.41 against an industry PE of 42.17 and a market cap of Rs 82,353 crore. Net profit has compounded at 74.55% a year since FY22, and FY26 revenue rose 100.94% while June 2026 quarter net profit grew 103.47%. Long-term returns in profit growth above long-term average stocks depend on earnings growth and the price paid at entry, so staggering purchases and consulting a SEBI-registered advisor is sensible.

Can Coforge become a multibagger from here?

Ans. Coforge has already gained 73.24% in five years, so another multi-fold move would need sustained earnings growth. A multibagger outcome in profit growth above long-term average stocks requires earnings to keep growing faster than the market for several years. Net profit has compounded at 23.72% a year since FY22, and FY26 revenue rose 34.63%. At a PE of 46.24 against an industry PE of 17.66, valuation should be checked against that growth before investing.

What is the market cap of Coforge, MCX, SRF and Fortis Healthcare?

Ans. As of 28 October 2026, Coforge has a market cap of Rs 88,796 crore, MCX has a market cap of Rs 82,353 crore, SRF has a market cap of Rs 74,551 crore and Fortis Healthcare has a market cap of Rs 57,814 crore. All of them qualify as midcaps. Market cap changes daily with the share price, so check the latest figure on the Univest Screener or on NSE before taking a decision on profit growth above long-term average stocks.

What are the risks of investing in profit growth above long-term average stocks?

Ans. The main risks are market swings, slower growth than expected and valuations that already reflect good news. Companies with strong balance sheets and steady earnings handle these better. Coforge trades at a PE of 46.24 against an industry PE of 17.66, so earnings growth needs to hold up.

Why is Coforge trading at a PE of 46.24?

Ans. Coforge’s PE of 46.24 compares with an industry PE of 17.66. The market is paying a premium for a return on equity of 16.31%, profit growth of 23.72% a year since FY22 and latest-quarter profit growth of 49.19%, which also means the stock is more sensitive if growth slows. Investors in profit growth above long-term average stocks who are comfortable with higher valuation risk may prefer to stagger purchases instead of investing in one go.

How much do institutions hold in Coforge, MCX, SRF and Fortis Healthcare?

Ans. As of the latest reported quarter, FII and DII together hold 66.93% of Coforge (24.31% and 42.62%), 80.65% of MCX (29.84% and 50.81%), 37.89% of SRF (15.45% and 22.44%) and 57.43% of Fortis Healthcare (25.20% and 32.23%). Rising institutional holding is a useful signal in profit growth above long-term average stocks, though it should be read with earnings trends rather than on its own.